Why Coherus Biosciences Popped Today
Coherus is divesting its non-core ophthalmology franchise.
Eli Lilly, McKesson, Novartis Flash Promising Chart Action
Eli Lilly, McKesson, and Novartis are catching investors' attention with promising chart patterns and revenue growth, signaling potential buying opportunities.